AI solution that assists the radiologist in the diagnosis and monitoring of neurodegenerative diseases in MRI.

Aimed at patients with diagnosed or suspected neurodegenerative disease, Pixyl.neuro.BV™ automatically analyses the MRI scan to provide detailed quantification of brain volume and atrophy.

Automatic detection, quantification and characterisation of volumes in anatomical areas of interest:

Whole brain, cerebrospinal fluid, ventricles or more specific structures such as hippocampus, frontal, parietal, temporal cortex, basal ganglia, thalamus and corpus callosum. For research purposes, Pixyl.Neuro.BV is able to segment more than 100 regions.

Report and longitudinal analysis of the evolution of the disease in case of presence of a history in the PACS :

Pixyl.neuro.BV™ automatically performs brain volume measurements and provides quantification in ml of the areas studied, all compared to a normative population to alert the user if an abnormal volume is detected. If the previous examination is available, it is automatically included in the analysis and allows the report to be completed with volume changes in percentages. This report also contains graphical representations of volumes and norms for certain areas.

  • multiple sclerosis
  • T2 FLAIR
  • T1 GADO
  • injury load
  • MRI
  • detection
  • longitudinal analysis

Standardise the follow-up of your patients


Standardise the follow-up of your patients and the transmission of results to the prescriber.   

Facilitate your diagnosis/monitoring


Facilitate your diagnosis/follow-up on the pathologies concerned (e.g. assessment of hippocampal atrophy in Alzheimer’s disease).

Integrate AI support


Integrate AI support directly into your existing infrastructure and your usual clinical workflow.

Save time, secure your diagnosis and optimise your workflow with Incepto

Pixyl is a young French startup, founded in and based in Grenoble. Its management team comes from INSERM and INRIA. At the crossroads of medicine, data science and software development, Pixyl aims to revolutionise brain imaging by offering a quantified analysis of biomarkers of neurodegenerative and neuroinflammatory diseases. Their cutting-edge technology based on Deep Learning, allowed them to finish as winners of the French Society of Radiology’s 2019 Data Challenge.

The Pixyl.Neuro.BV medical device is a regulated health product and bears the CE mark, Class IIa. Notified body: TÜV Rheinland. No. 0197. Manufacturer: Pixyl.

Pixyl.Neuro.BV is a diagnostic tool and should not be used on its own to recommend medical treatment for diagnostic purposes. Please read the instructions in the user manual carefully.

Please contact contact@incepto-medical.com for more information. Last update: 14/02/2023

Save time, secure diagnosis and optimize your workflow with Incepto